[HTML][HTML] Current and emerging therapies for metastatic castration-resistant prostate cancer (mCRPC)
Metastatic castration-resistant prostate cancer (mCRPC) encompasses a heterogeneous
wide range of molecular tumor behavior and a high risk of progression. Early detection and …
wide range of molecular tumor behavior and a high risk of progression. Early detection and …
[PDF][PDF] Current and Emerging Therapies for Metastatic Castration-Resistant Prostate Cancer (mCRPC). Biomedicines 2021, 9, 1247
I Henríquez, M Roach III, TM Morgan, A Bossi… - 2021 - pdfs.semanticscholar.org
Metastatic castration-resistant prostate cancer (mCRPC) encompasses a heterogeneous
wide range of molecular tumor behavior and a high risk of progression. Early detection and …
wide range of molecular tumor behavior and a high risk of progression. Early detection and …
Current and Emerging Therapies for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
I Henríquez, M Roach III, TM Morgan, A Bossi… - …, 2021 - search.proquest.com
Metastatic castration-resistant prostate cancer (mCRPC) encompasses a heterogeneous
wide range of molecular tumor behavior and a high risk of progression. Early detection and …
wide range of molecular tumor behavior and a high risk of progression. Early detection and …
Current and Emerging Therapies for Metastatic Castration-Resistant Prostate Cancer (mCRPC).
I Henríquez, M Roach 3rd, TM Morgan, A Bossi… - Biomedicines, 2021 - europepmc.org
Metastatic castration-resistant prostate cancer (mCRPC) encompasses a heterogeneous
wide range of molecular tumor behavior and a high risk of progression. Early detection and …
wide range of molecular tumor behavior and a high risk of progression. Early detection and …
[HTML][HTML] Current and Emerging Therapies for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
I Henríquez, M Roach III, TM Morgan, A Bossi… - …, 2021 - ncbi.nlm.nih.gov
Metastatic castration-resistant prostate cancer (mCRPC) encompasses a heterogeneous
wide range of molecular tumor behavior and a high risk of progression. Early detection and …
wide range of molecular tumor behavior and a high risk of progression. Early detection and …
[引用][C] Current and Emerging Therapies for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
I Henriquez, TM Morgan, A Bossi, JA Gomez… - Biomedicines …, 2021 - jglobal.jst.go.jp
Current and Emerging Therapies for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
| Article Information | J-GLOBAL Art J-GLOBAL ID:202202288287689130 Reference number:22A2057926 …
| Article Information | J-GLOBAL Art J-GLOBAL ID:202202288287689130 Reference number:22A2057926 …
Current and Emerging Therapies for Metastatic Castration-Resistant Prostate Cancer (mCRPC).
I Henríquez, M Roach III, TM Morgan, A Bossi… - …, 2021 - search.ebscohost.com
Metastatic castration-resistant prostate cancer (mCRPC) encompasses a heterogeneous
wide range of molecular tumor behavior and a high risk of progression. Early detection and …
wide range of molecular tumor behavior and a high risk of progression. Early detection and …
Current and Emerging Therapies for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
I Henríquez, M Roach 3rd, TM Morgan… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Metastatic castration-resistant prostate cancer (mCRPC) encompasses a heterogeneous
wide range of molecular tumor behavior and a high risk of progression. Early detection and …
wide range of molecular tumor behavior and a high risk of progression. Early detection and …
Current and Emerging Therapies for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
I Henríquez, M Roach, TM Morgan, A Bossi, JA Gómez… - 2021 - agris.fao.org
Metastatic castration-resistant prostate cancer (mCRPC) encompasses a heterogeneous
wide range of molecular tumor behavior and a high risk of progression. Early detection and …
wide range of molecular tumor behavior and a high risk of progression. Early detection and …
Current and Emerging Therapies for Metastatic Castration-Resistant Prostate Cancer (mCRPC).
I Henríquez, T Morgan, A Bossi, J Gómez… - …, 2021 - escholarship.org
Metastatic castration-resistant prostate cancer (mCRPC) encompasses a heterogeneous
wide range of molecular tumor behavior and a high risk of progression. Early detection and …
wide range of molecular tumor behavior and a high risk of progression. Early detection and …